Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age

Summary

The current study provides data necessary to evaluate the safety and immunogenicity of Serum Institute of India's PNEUMOSIL® \[Pneumococcal Polysaccharide Conjugate Vaccine Adsorbed (10-Valent)\] in Healthy Vietnamese Infants and Toddlers, 6 weeks to 24 months of age. This is an open label, prospective, bridging study.

Timeline

Start

2022-01-25

Primary completion

2022-02-28

Completion

2022-06-01

Publications

• Son VT, Anh BDT, Hoan VN, Than HV, Linh BK, Giang TH, Manh NT, Thao LTT, Cuong HX, Giang DT, Dat DT, Giang LTH, Mulay SC, Sethna V, Hung PV. Safety and Immunogenicity of SII's 10-Valent Pneumococcal Conjugate Vaccine (PCV10-SII) in Vietnamese Children Aged from 6 Weeks to 24 Months: An Open-Label, Single-Arm Bridging Study. Vaccines (Basel). 2026 Apr 10;14(4):336. doi: 10.3390/vaccines14040336.

Drugs

Indications